A Pre-Clinical Research for Treatment of Prematurity and BronchoPulmonary Dysplasia through Intracrinology

分泌内治疗早产儿和支气管肺发育不良的临床前研究

• 批准号: 380334
• 负责人: Tremblay Yves
• 金额: $ 34.27万
• 依托单位: CHU de Qubec
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-03-01 至 2021-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=380334&lang=en
• 关键词: Determinations, General Molecular Biology; Disease: Bronchopulmonary Dysplasia, Bpd, Alveolar; Lung Morphometry, Development Of Algorithm; Physiology, Steroid Metabolism/Action, Intracrinology; Simplification, Dhea. Expertise: Lung Endocrinology, Lung; Te

Treatments related to preterm birth and bronchopulmonary dysplasia (BPD) exert important financial constraints on the healthcare system. BPD is a disease arising as a consequence of preterm birth affecting lung structures. The subject of this research is

与早产和支气管肺发育不良(BPD)相关的治疗对医疗保健系统造成了重要的财政限制。BPD是一种由于早产影响肺结构而引起的疾病。这项研究的主题是